JPMorgan Climate Change Solutions ETF JPMorgan Climate Change Solutions Fund TEMP 深 沪
等待开盘 11-06 09:30:00 美东时间
51.605
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 51.605
- 总市值 774.08万
- 52周最高 51.805
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 37.28
- 委 比 0.00%
- 总股本 15.00万
- 历史最高 51.805
- 量 比 0
- 振 幅 0.00%
- 历史最低 31.144
- 每 手 1
- 风险率 0.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tempsens Confirms No Deviation in IPO Fund Utilisation
Tempsens Instruments (India) Limited ( ($IN:TEMPSENS) ) has provided an announc...
10-30 23:43
Fluke Introduces New Refrigerated Calibration Baths for High-Accuracy Temperature Sensor Testing
Fluke introduces new refrigerated calibration baths (7508, 7511, 7512) designed for high-accuracy temperature sensor testing. These baths offer exceptional stability (±0.0007°C) and uniformity (±0.003°C), reducing temperature variability and measurement uncertainty. They automate calibration tasks, support multiple sensor types, and simplify maintenance with features like direct-drive stirrers and CFC-free refrigerants. Ideal for metrology labs, ...
10-28 07:30
Tempus Capital Monetizes London Properties to Fund New Growth
Tempus Capital ( ($TSE:TEMP) ) has shared an update. Tempus Capital Inc. has ag...
10-02 02:49
AbbVie’s Juvmo wins FDA approval for Parkinson’s disease
The U.S. Food and Drug Administration (FDA) has approved AbbVie’s (ABBV) Juvmo (tavapadon) tablets as the first and only selective D1/D5 receptor agonist for treating adults with Parkinson’s disease. ...
09-28 20:19
Tempsens schedules global earnings call to discuss Q1 FY27 results
The latest announcement is out from Tempsens Instruments (India) Limited ( ($IN...
09-13 17:52
支持率不足1%：比特币治理面临8月强制切换危机
比特币的未来走向取决于能否选出保护核心功能的协议提案，并在紧急情况出现前取得各方一致同意，这是继早期硬分叉争议之后，比特币社区面临的又一次严峻治理考验。
08-03 17:20
Dexcom selected as first company in FDA digital health services pilot
The US FDA has chosen Dexcom (DXCM) as the first participant in its Technology-Enabled Meaningful Patient Outcomes (TEMPO) Pilot Program. The continuous glucose monitor maker said it would "implement...
07-23 05:39
Corbus Pharmaceuticals appoints Leonardo Viana Nicacio as Chief Medical Officer
Corbus Pharmaceuticals Holdings (CRBP) announced the appointment of Leonardo Viana Nicacio as Chief Medical Officer. Nicacio brings over 20 years of pharmaceutical and oncology experience, notably ser...
07-06 20:14
